Lacerta Therapeutics Strengthens Its Position in the AAV Gene Therapy Space With New Leadership
UF startup and UF Innovate | Sid Martin Biotech alum Lacerta Therapeutics, a clinical-stage gene therapy company, announced new leadership. Dr. Edgar... Read More
Therapeutics Company Announces Exclusive Licensing Agreements for Hearing Loss Gene Therapy Technology Developed by UF Researcher
Decibel Therapeutics, a clinical-stage biotechnology company developing novel restorative gene therapeutics to treat hearing loss and balance disorders, has announced exclusive license... Read More
Dr. Adrian Tyndall Named Associate Vice President for Strategic and Academic Affairs for UF Health
Adrian Tyndall, M.D., M.P.H., has been named to a new system-level role as associate vice president for strategic and academic affairs for... Read More
UF Health Enrolls First Patient in Clinical Trial Aimed at Creating New Treatment for COVID-19
University of Florida Health has enrolled its first patient in a clinical trial for Regeneron Pharmaceuticals’ monoclonal antibody cocktail to treat COVID-19,... Read More
Inventors Honored at Virtual Standing InnOvation Event
More than 200 innovators participated in a live-stream event and virtual happy hour to celebrate their achievements in fiscal year 2020. The... Read More
Trials Begin for a New Weapon Against Parkinson’s: Light
Light therapy can help lift moods, heal wounds, and boost the immune system. Can it improve symptoms of Parkinson’s disease, too? A... Read More
UF Researcher Works With Bionano Data to Provide Understanding of Repeat Expansion Disorders Causing Muscular Dystrophy and ALS
Bionano Genomics, Inc. announced that teams from the Mayo Clinic and from the University of Florida have separately released results generated with... Read More
Trio of Medications Showing Early Promise Against Coronavirus, UF Health Researchers Find
The race to find effective treatments for COVID-19 isn’t just about developing new drugs. University of Florida Health scientists are studying a... Read More
Five Questions for Michael S. Okun, M.D.
Michael S. Okun, M.D. is chair of Neurology, Adelaide Lackner professor, and executive director of the Norman Fixel Institute for Neurological Diseases... Read More
UF Neuroscientist Earns NIH Maximizing Investigators’ Research Award
A UF neuroscientist has earned a $1.86 million NIH award to further his lab’s research into the actin cytoskeleton, an integral component... Read More
